HPV-16 Tied to Improved Survival in Advanced Esophageal Cancer
Improved survival and treatment response for HPV-16 positive patients
Rush University Adds Patient Scores to Doctor Profiles
Scores based on 30 or more patient surveys completed in one-year period
Correlated Spectroscopy IDs Changes in BRCA1/2 Carriers
Lipid and metabolite deregulation seen in breast tissue of women carrying BRCA1/2 mutations
FDA: Opdivo Approval Expanded to Include Lung Cancer
FDA approves drug for NSCLC patients who have been treated with platinum-based chemotherapy
Research Measures Perceptions of Physician Compassion
Patients perceive higher level of compassion among physicians who provide a more optimistic message
February 2015 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for February 2015. This roundup includes...
L858R Mutation in Circulating Free DNA Is Prognostic in NSCLC
L858R mutation in tumor tissue or cfDNA is marker of shorter overall, progression-free survival
Hospital Design Has Little Effect on Patient Satisfaction
Aesthetics aren't as important as care from doctors, nurses, and staff, researchers note
Genitourinary Cancers Symposium, Feb. 26-28
The 2015 Genitourinary Cancers Symposium The American Society of Clinical Oncology's annual Genitourinary Cancers Symposium was held from Feb. 26 to 28 in...
Genetic Mutations Found in Leukemia Rise With Age
But just having cancer-linked DNA doesn't mean the disease will develop, study authors stress
